Skip to main content
Equibles
DRUG logo

DRUG · Bright Minds Biosciences Inc.

Track DRUG — free

Use DRUG with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about DRUG

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$72.81 -1.73 (-2.31%) At close · Aug 28
Russell 2000 member Rebalance outlook locked
Market Cap
$741.06M
Shares
9.81M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Net Income
-2.8M +62%
FY2024 Net Income FY2020–FY2024
Operating Cash Flow
-1.85M +73.7%
FY2024 Operating Cash Flow FY2020–FY2024

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
CAD 1.18M 5M 12.18M 6.31M 354.85K —
CAD 41.6K 119.42K 551.86K 852.15K 9618 —
CAD 264.01K 278.81K 478.25K 197.13K 637 —
CAD 0 0 0 0 0 0
CAD -2.8M -7.37M -14.96M -2.8M -480.38K —
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Key facts CIK 1827401 CUSIP 10919W405 13F (30d) 94 filings 93 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)